Yorvipath — Blue Cross Blue Shield of Montana

Initial criteria

• The member resides in Ohio AND
• The plan is Fully Insured or HIM Shop (SG) AND
• The patient does NOT have any FDA labeled contraindications to the requested agent AND
• ONE of the following: (A) The patient has another FDA labeled indication for the requested agent and route of administration OR (B) The patient has another indication that is supported in compendia for the requested agent and route of administration OR (C) The prescriber has submitted two peer-reviewed journal articles supporting the proposed use as generally safe and effective

Approval duration

36 months (BCBSOK); 12 months (others)